AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine

NCT00326872 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

26

Enrollment

NIH

Sponsor class

Stopped Closed due to slow accrual prior to interim analysis.

Conditions

Neurofibromatosis Type 1
Plexiform Neurofibroma
Spinal Cord Neurofibroma

Interventions

DRUG: Cediranib Maleate

Sponsor

National Cancer Institute (NCI)